Latest News and Press Releases
Want to stay updated on the latest news?
-
BioStem Technologies Reports Preliminary First Quarter 2025 Operating and Financial Results
-
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
-
BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025
-
BioStem Technologies to Present at the Centri Capital Conference
-
BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million Full-Year 2024 Revenue of $301.8 Million
-
BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
-
BioStem Technologies Announces Extension to File 2024 Annual Report with OTC
-
BioStem Announces Notice of Allowance for Two U.S. Patent Applications
-
BioStem Technologies to Present at the 24th Annual Needham Virtual Healthcare Conference
-
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology